Sindbis virus — Questions

A complete answer covers the incubation and onset, the characteristic rash and arthritis, the usual course and recovery, the chronic joint sequela, and brief epidemiological framing.

Incubation and onset. After an incubation of about two to eight days, the illness begins abruptly, with fever, rash and joint pain arising together over a short period during a brief viraemia.

Rash. A maculopapular, often intensely itchy rash spreads over the trunk and limbs and may involve the palms and soles; individual lesions can develop a central vesicle, and the rash is occasionally haemorrhagic.

Arthritis. Arthralgia and arthritis favour the larger joints, the ankles, knees, wrists and elbows, and may be severe enough to limit movement, accompanied by myalgia and malaise.

Course and recovery. The illness is self-limited, settling in most people within about two weeks, and the great majority recover completely; severe or fatal disease is rare, and infection confers lasting immunity.

Chronic sequela. In about a third of patients, arthralgia and joint stiffness persist for months and sometimes years after the acute illness, the principal long-term morbidity.

Epidemiological framing. The disease is a seasonal late-summer illness of northern Europe (where it is called Pogosta fever, Ockelbo disease and Karelian fever) and of southern Africa, arising as a spillover from a wild-bird and mosquito cycle.

About a third of patients have arthralgia and joint stiffness that persist for months and sometimes years after the acute illness, the main long-term morbidity.

The other outcomes are not features of Sindbis infection.

After E2-mediated attachment, the virus enters by clathrin-mediated endocytosis, and the acid endosome triggers E1 to fuse the membranes, releasing the nucleocapsid into the cytoplasm.

Entry is not neutral-pH fusion, genome injection, receptor-independent, or nuclear.

Diagnosis is usually serological, with virus-specific IgM detectable in the acute illness and a rising IgG on paired sera; reverse-transcription PCR and isolation are possible early, when the patient still has viraemia.

Bacterial culture, cerebrospinal fluid microscopy, biopsy alone and stool antigen are not the approach.

Clinical Sindbis disease in northern Europe clusters in middle-aged adults, women more than men, in the late-summer season of peak mosquito activity.

It is not primarily a disease of children, infants, the elderly or travellers.

Sindbis is an Old World arthritogenic alphavirus, causing fever, rash and arthritis, and sits in the Western equine encephalitis antigenic complex despite its non-encephalitic disease.

The other groupings are separate genera or the encephalitic New World clade.

These northern European names, from Finland, Sweden and Russia, all denote Sindbis virus disease.

Chikungunya and Ross River are other arthritogenic alphaviruses, and West Nile and tick-borne encephalitis are encephalitic flaviviruses.

Sindbis is the prototype alphavirus, isolated in 1952 near the village of Sindbis in the Nile Delta of Egypt, and became the reference virus for alphavirus structure and replication.

It is an Old World arthritogenic virus, not encephalitic, New World or tick-borne, and its outbreaks are modest rather than the largest recorded.

The incubation period is about two to eight days, after which fever, rash and arthralgia begin together.

The other intervals are far too short or too long.

There is no specific antiviral and no licensed vaccine, so care is supportive and prevention rests on avoiding mosquito bites in the wetland and woodland settings where the vectors are active.

The other measures do not apply to Sindbis virus.

Sindbis is maintained between wild passerine birds and ornithophilic Culex and Culiseta mosquitoes, with migratory birds dispersing it over long distances.

Humans are incidental hosts, and the other host and vector pairings belong to different arboviruses.

The rash is maculopapular and often intensely itchy, spread over the trunk and limbs and sometimes involving the palms and soles, occasionally with a central vesicle or a haemorrhagic quality.

It is neither dermatomal, purely petechial, nor an ulcer.

In the mouse, Sindbis is the classic model of age-dependent viral encephalomyelitis, but human infection spares the nervous system and produces an arthritis, driven by macrophage inflammation rather than direct cell killing.

It does not cause encephalitis in people, is not neuron-restricted in humans, and has a wild-bird reservoir.

South Africa is one of the two principal foci of Sindbis disease, and the close genetic link between its strains and the northern European strains shows the virus is carried between them by migratory birds.

It reports regular summer cases, is not tick-borne, and has no vaccine-based elimination.

Sindbis is an enveloped, roughly 70 nm particle with a single positive-sense RNA genome of about 11.7 kb, expressed as nonstructural and structural protein sets.

It is not non-enveloped, DNA, segmented or double-stranded, and it is E2 that attaches while E1 fuses.